A combined rule based on HBsAg Levels and HBV DNA levels predicts risk of HBV reactivation in patients in the immune control phase of CHB

GS Burns, JA Holmes, R Goldberg, R Trethowan, A Wong, O Cronin, NA Kuruvilla, T Nguyen, RG Shaw, RY Chen, BH Demediuk, SJ Bell, SA Locarnini, DS Bowden, PV Desmond, AJ Thompson